ストックスクリーナーアプリを入手
0.81
0.12%
-0.001
アフターアワーズ：
.83
0.02
+2.47%
前日終値:
$0.811
開ける：
$0.8088
24時間の取引高:
792.37K
Relative Volume:
0.79
時価総額：
$1.01M
収益：
$9.00M
当期純損益:
$-7.21M
株価収益率:
-1.4727
EPS:
-0.55
ネットキャッシュフロー:
$-7.59M
1週間 パフォーマンス:
-11.58%
1か月 パフォーマンス:
-54.75%
6か月 パフォーマンス:
-95.68%
1年 パフォーマンス:
-99.76%
1日の値動き範囲:
$0.723
$0.838
1週間の範囲:
$0.723
$0.90
52週間の値動き範囲:
$0.723
$355.10
Applied Dna Sciences Inc Stock (APDN) Company Profile
名前
Applied Dna Sciences Inc
セクター
電話
631-240-8800
住所
50 HEALTH SCIENCES DRIVE, STONY BROOK, NY
APDN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
APDN
Applied Dna Sciences Inc
|
0.81 | 1.01M | 9.00M | -7.21M | -7.59M | -0.55 |
|
TMO
Thermo Fisher Scientific Inc
|
421.85 | 169.62B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
184.96 | 138.06B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
406.65 | 32.79B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
100.26 | 29.99B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
141.22 | 26.61B | 15.41B | 1.37B | 2.11B | 7.50 |
Applied Dna Sciences Inc Stock (APDN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-02-12 | 開始されました | ROTH Capital | Buy |
| 2021-01-14 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-12-18 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-07-20 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-07-02 | 開始されました | H.C. Wainwright | Buy |
| 2016-11-14 | 繰り返されました | Maxim Group | Buy |
| 2016-05-13 | 繰り返されました | Maxim Group | Buy |
| 2015-10-08 | 繰り返されました | Maxim Group | Buy |
| 2015-05-26 | 開始されました | The Benchmark Company | Speculative Buy |
| 2015-02-10 | 繰り返されました | Maxim Group | Buy |
| 2015-01-13 | 開始されました | Maxim Group | Buy |
すべてを表示
Applied Dna Sciences Inc (APDN) 最新ニュース
Applied DNA secures U.S. supply chain for key materials By Investing.com - Investing.com India
Applied DNA Sciences (APDN) Enhances U.S. Supply Chain for Genetic Medicine Platforms | APDN Stock News - GuruFocus
Applied DNA secures U.S. supply chain for key materials - Investing.com
Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA | APDN Stock News - GuruFocus
Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA - standard-journal.com
Press Release Distribution & PR Platform - ACCESS Newswire
US Biotech Leader LineaRx Transforms DNA Manufacturing with Major Domestic Supply Chain Shift - Stock Titan
APDN stock plunges to 52-week low at $0.89 amid market challenges By Investing.com - Investing.com South Africa
APDN stock plunges to 52-week low at $0.89 amid market challenges - Investing.com Canada
Applied DNA regains compliance with Nasdaq minimum bid price rule - MSN
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Applied DNA regains Nasdaq compliance with bid price By Investing.com - Investing.com South Africa
Applied DNA Sciences Regains Nasdaq Compliance on Minimum Bid Price Rule - MarketScreener
Applied DNA Sciences regains Nasdaq compliance with stock price By Investing.com - Investing.com South Africa
Applied DNA regains Nasdaq compliance with bid price - Investing.com
Applied DNA Sciences regains Nasdaq compliance with stock price - Investing.com
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement - Weatherford Democrat
Applied DNA Overcomes Delisting Threat: Successfully Maintains Nasdaq Standards - Stock Titan
APDN stock plunges to 52-week low at $1.14 amid steep decline - Investing.com Australia
APDN stock plunges to 52-week low at $1.14 amid steep decline By Investing.com - Investing.com South Africa
Applied DNA sets May 22 for virtual shareholder meeting By Investing.com - Investing.com India
Applied DNA sets May 22 for virtual shareholder meeting - Investing.com
Growth or Bubble? APDN’s Unexpected Surge - timothysykes.com
Why Applied DNA Sciences (APDN) Stock Is Rising - Benzinga
Applied DNA refines pharmacogenomics strategy By Investing.com - Investing.com Australia
Applied DNA refines pharmacogenomics strategy - Investing.com
Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement - ACCESS Newswire
Critical FDA Safety Alert Powers Applied DNA's New Cancer Drug Testing Solution - Stock Titan
APDN stock plunges to 52-week low at $1.63 amid steep decline - Investing.com Canada
Applied DNA seeks NY approval for bird flu test By Investing.com - Investing.com South Africa
Applied DNA Seeks New York Approval for H5 Bird Flu Test - MarketScreener
Applied DNA Sciences submits request to NYSDOH for H5 bird flu LDT approval - TipRanks
Applied DNA seeks NY approval for bird flu test - Investing.com Australia
Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test - ACCESS Newswire
New H5 Bird Flu Test Advances: Applied DNA's Dual-Detection System Nears Market Launch - Stock Titan
Applied DNA to Participate in Maxim Group’s COVID-19 Virtual Conference Series on May 27 - Business Wire
Just Style - Just Style
APDN Stock Plummets: Opportunity or Warning? - timothysykes.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025 - Galveston County Daily News
Applied DNA announces 1-for-50 reverse stock split - MSN
APDN stock plunges to 52-week low of $0.09 amid market challenges - Investing.com
Applied DNA Sciences Approves Reverse Stock Split - TipRanks
Applied DNA Sciences to Implement 1-for-50 Reverse Stock Split; Shares Fall -March 12, 2025 at 11:14 am EDT - Marketscreener.com
Applied DNA announces 1-for-50 reverse stock split By Investing.com - Investing.com Australia
Applied DNA Sciences Says 1-For-50 Reverse Stock Split Of Issued And Outstanding Common Stock Effective March 14 - Marketscreener.com
APDN stock plunges to 52-week low of $0.09 amid market challenges By Investing.com - Investing.com South Africa
Applied Dna Sciences Inc (APDN) 財務データ
収益
当期純利益
現金流量
EPS
1.18%
大文字化:
|
ボリューム (24 時間):